Tenet Healthcare holds the cleaner structural position, with the lead spread across profitability and growth. Fresenius Medical Care does not offset that deficit through any equally strong structural edge elsewhere. The market setup broadly confirms the structural lead — Tenet Healthcare holds the more constructive position. That puts structure and market broadly in agreement — Tenet Healthcare's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (FME.DE: DAX 40, THC: Russell 1000).
The clearest separation starts in profitability, with growth adding a second layer of support. Tenet Healthcare Corporation leads by 24 points on the overall comparison score.
Both operate in: Medical Care Facilities
This comparison is based on industry proximity, not on functional trajectory similarity. FME.DE and THC share the same industry classification.
For a similarity-based comparison, see how Fresenius Medical Care and Tenet Healthcare each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Tenet Healthcare Corporation looks stronger on relative valuation, while the broader price setup remains mixed.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where FME.DE and THC each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability lead is mainly driven by a 9.8-point operating margin advantage.
Fresenius Medical Care AG still looks less cycle-sensitive — that keeps the result from looking completely one-sided.
The lead is built on both profitability and growth, making it broader than a single-dimension result.
Break down the FME.DE vs THC comparison across all dimensions with the full interactive tool.
Explore how FME.DE and THC each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.